CTU Bern

Reference Projects


MASTER DAPT was a global randomized-controlled trial to evaluate the appropriate duration of dual antiplatelet therapy in patients with coronary artery disease at high risk for bleeding. Read more


OPERAM was a cluster randomized controlled trial to examine the effect of optimizing drug treatment on drug-related hospital admissions in older adults with multimorbidity and polypharmacy ad- mitted to hospital. Read more


SWIFT-DIRECT is a multicenter, randomized controlled clinical trial to assess whether thrombectomy alone is non-inferior to intravenous alteplase plus thrombectomy for treating acute stroke patients with large vessel occlusions. Read more

HemMa Study

HemMa is a prospective cross-sectional observational study that aims to identify hematological markers in patients with sickle cell disease. The study is a collaboration between the Biologics Research Center of CSL Behring at SITEM and the Department of Hematology of the University Hospital (Inselspital) Bern. CTU Bern is involved in designing, implementing, conducting, and analyzing the study. Read more